Noncarriers relative to carriers of both APOE4 and BCHE-K had higher CSF indices of tau pathophysiology, synaptic injury, glial activation, and multidomain cognitive deficits, but memory impairments were less severe (Table 2). The gene discussed is MAPT; the disease is Cognitive impairment.